2008•Yearbook of MedicineRequires access

B Cell Depletion May Be More Effective Than Switching to an Alternative Anti–Tumor Necrosis Factor Agent in Rheumatoid Arthritis Patients With Inadequate Response to Anti–Tumor Necrosis Factor Agents

Seth Mark Berney

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Rheumatoid arthritis, Tumor necrosis factor alpha, Medicine, Tumor necrosis factor α, Necrosis, Cancer research, Immunology, Antirheumatic Agents

Back to paper search Browse research topics Original source

B Cell Depletion May Be More Effective Than Switching to an Alternative Anti–Tumor Necrosis Factor Agent in Rheumatoid Arthritis Patients With Inadequate Response to Anti–Tumor Necrosis Factor Agents — Research Paper | ScholarLens